Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis

BACKGROUND: Recent trials have provided robust evidence demonstrating that endocrine therapy with/without targeted therapy, such as cyclin-dependent kinase 4/6 inhibitors or mTOR (mammalian target of rapamycin) inhibitors, effectively halts disease progression in hormone receptor (HR)-positive and h...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Care (Basel)
Hlavní autoři: Cha, Chihwan, Ahn, Sung Gwe, Yoo, Tae-Kyung, Kim, Kun Min, Bae, Soong June, Yoon, Changik, Park, Soeun, Sohn, Joohyuk, Jeong, Joon
Médium: Artigo
Jazyk:Inglês
Vydáno: S. Karger GmbH 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490659/
https://ncbi.nlm.nih.gov/pubmed/32982652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503847
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky